If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 91 - 100 of 279
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Objective
Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)
Protocol No
GI-YARUR-SPARC
Categories
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults (PREVENTABLE)
Objective
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr adults
Protocol No
GIM-DUKE-PREVENTABLE
PRECIDENTD: PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Objective
PREvention of Cardovascular and DiabEtic kidNey Disease in Type 2 Diabetes
Protocol No
GIM-PCORI-PRECIDENTD
Categories
The Effect of Housing Instability and Neighborhood Deprivation on Maternal Health - HOME study
Objective
Housing Instability and Neighborhood Deprivation on Maternal Health
Protocol No
IHE-IIT-JDG-HOME
Categories
The Effect of Intraoperative Brain Stimulation on Hand Strength and Function During Awake Craniotomies
Objective
Intraoperative Hand Function
Protocol No
IIT-KRUCOFF-INTRAOP-HAND-FUNC
Categories
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients With Treatment-refractory Mycobacterium Avium Complex Lung
Objective
Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease
Protocol No
INF-AN2-EBO-301-MAC
Categories
Expanded Access IND Protocol: Use of Tecovirimat (TPOXX) for Treatment of Human Orthopoxvirus Infections (CDC IND 116039, CDC IRB Protocol #6402)
Objective
TPOXX for Treatment of Human Orthopoxvirus Infections
Protocol No
INF-CDC-TPOXX-EA-IND-MONKEYPOX
Categories
A Phase 2b Multicenter, Randomized, Open-Label Study Comparing the Efficacy, Safety, PK, and Tolerability of VH3810109, Administered Either Intravenously Or As A Subcutaneous Infusion with rHuPH20, in Combination with CAB LA to Standard of Care in Vi
Objective
HIV Embrace
Protocol No
INF-GSK-EMBRACE-HIV
Categories
A Multicenter, Adaptive, Randomized, Controlled, Trial Platform to Evaluate Safety and Efficacy Strategies and Treatments for Hospitalized Patients with Respiratory Infections
Objective
Safety, Efficacy and Tx Strategies for Hospitalized Patients with Respiratory Infections
Protocol No
INF-NIAID-STRIVE
Categories
An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)
Objective
Study Evaluating Safety and Efficacy of JCAR017 in Subject with rrCLL or SLL
Protocol No
JUNO-017004-TRANSCEND-CLL
Categories